These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 2130204)
1. [Myelodysplastic syndrome: experience of the Study and Treatment of Bone Marrow Failure Group]. Goldztein S; Nucifora E; Blasetti A; Fantl D; González N; Saslavsky J; Annetta I; Calahonra R; Binaghi A; de Di Risio CB Medicina (B Aires); 1990; 50(3):189-97. PubMed ID: 2130204 [TBL] [Abstract][Full Text] [Related]
2. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications. Lorand-Metze I; Pinheiro MP; Ribeiro E; de Paula EV; Metze K Leuk Res; 2004 Jun; 28(6):587-94. PubMed ID: 15120935 [TBL] [Abstract][Full Text] [Related]
3. Physician Education: Myelodysplastic Syndrome. Yoshida Y Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004 [TBL] [Abstract][Full Text] [Related]
4. Acute erythroid neoplastic proliferations. A biological study based on 62 patients. Domingo-Claros A; Larriba I; Rozman M; Irriguible D; Vallespí T; Aventin A; Ayats R; Millá F; Solé F; Florensa L; Gallart M; Tuset E; Lopez C; Woessner S Haematologica; 2002 Feb; 87(2):148-53. PubMed ID: 11836165 [TBL] [Abstract][Full Text] [Related]
5. [Myelodysplasias: clinical experience with 35 patients]. Chuecas F; Grebe G; Jalil R; Lira P Rev Med Chil; 1990 Nov; 118(11):1211-7. PubMed ID: 2152645 [TBL] [Abstract][Full Text] [Related]
12. Myelodysplastic syndromes in patients under 50 years old: a single institution experience. Breccia M; Mengarelli A; Mancini M; Biondo F; Gentilini F; Latagliata R; Mandelli F; Alimena G Leuk Res; 2005 Jul; 29(7):749-54. PubMed ID: 15927670 [TBL] [Abstract][Full Text] [Related]
13. Detection of risk groups in myelodysplastic syndromes. A multicenter study. Belli C; Acevedo S; Bengio R; Arrossagaray G; Watman N; Rossi N; García J; Flores G; Goldztein S; Larripa I Haematologica; 2002 Jan; 87(1):9-16. PubMed ID: 11801460 [TBL] [Abstract][Full Text] [Related]
14. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden. Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940 [TBL] [Abstract][Full Text] [Related]
15. [Study on prognostic factors in twenty-five patients with myelodysplastic syndrome]. Toyama T; Uno H; Yamashita K; Kubuki Y; Suzuki M; Maeda K; Matsuoka H; Tsubouchi H Gan To Kagaku Ryoho; 1995 Feb; 22(2):227-32. PubMed ID: 7857097 [TBL] [Abstract][Full Text] [Related]
16. [Retrospective study of 30 cases of myelodysplastic syndrome according to the French-American-British classification]. Piguet D; Schmidt PM; Delacrétaz F; Mermillod B Schweiz Med Wochenschr; 1987 Jan; 117(2):61-6. PubMed ID: 3468610 [TBL] [Abstract][Full Text] [Related]
17. [Immunological indices in myelodysplastic syndromes]. Luraschi A; Saglietti G; Fedeli P; Gioria A; Della Vedova A; Ferrari V; Borgotti P Minerva Med; 1994 Apr; 85(4):145-53. PubMed ID: 8028741 [TBL] [Abstract][Full Text] [Related]
19. The role of bone marrow study in diagnosis and prognosis of myelodysplastic syndrome. Saad ST; Vassallo J; Arruda VA; Lorand-Metze I Pathologica; 1994 Feb; 86(1):47-51. PubMed ID: 8072801 [TBL] [Abstract][Full Text] [Related]
20. Cyclosporin A in myelodysplastic syndrome: a preliminary report. Dixit A; Chatterjee T; Mishra P; Choudhary DR; Mahapatra M; Saxena R; Choudhry VP Ann Hematol; 2005 Sep; 84(9):565-8. PubMed ID: 15809884 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]